System Transmission

Top Signal

100#1 JOB

Activity

2168Ripe

+924 today

System

Livenow

Terminal Asset View

stockNASDAQ

AEON

$1.11-5.13%

AEON Biopharma Inc - Class A

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

25Overripe

Live Analysis Active

Company Mission

AEON Biopharma is a biotechnology company that develops treatments for migraine headaches. They create experimental drugs that are tested in clinical trials with patients who suffer from migraines. The company makes money by advancing these treatments through research phases and hopes to eventually sell successful drugs to pharmaceutical companies or directly to patients.

AEO

Industry Context

Biotechnology companies develop medical treatments and drugs. They often have volatile stock prices because their value depends heavily on whether their experimental treatments succeed in clinical trials. When trial results are announced, prices can move dramatically based on whether the news is positive or negative.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

78Matrix

Market Momentum

50.2— Holding Steady

Trend Strength

50— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.8x— Normal Volume

Today's Change

-5.13%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing AEON across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 05:55 PM UTC

As-of 03-14-2026 17:40 UTC

Develops migraine treatments and makes money by selling these prescription drugs to patients through pharmacies and hospitals.

Weekly price range is narrowing near recent levels, suggesting a potential breakout or breakdown is approaching.

Biotech sector volatility often increases during clinical trial phases, which could impact price movements for this company.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...